PMC:7352545 / 77928-78134 JSONTXT

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T220","span":{"begin":160,"end":166},"obj":"https://glytoucan.org/Structures/Glycans/G81533KY"}],"text":" the S glycoprotein of SARS-CoV-2. Using molecular modeling and simulation technology, CLQ has been suggested to recognize the SAs and gangliosides. Human type Neu5Ac binds to CLQ and CLQ-OH. Thus, SAs are "}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T743","span":{"begin":7,"end":19},"obj":"Body_part"},{"id":"T744","span":{"begin":135,"end":147},"obj":"Body_part"}],"attributes":[{"id":"A743","pred":"fma_id","subj":"T743","obj":"http://purl.org/sig/ont/fma/fma62925"},{"id":"A744","pred":"fma_id","subj":"T744","obj":"http://purl.org/sig/ont/fma/fma82816"}],"text":" the S glycoprotein of SARS-CoV-2. Using molecular modeling and simulation technology, CLQ has been suggested to recognize the SAs and gangliosides. Human type Neu5Ac binds to CLQ and CLQ-OH. Thus, SAs are "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T311","span":{"begin":23,"end":31},"obj":"Disease"}],"attributes":[{"id":"A311","pred":"mondo_id","subj":"T311","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" the S glycoprotein of SARS-CoV-2. Using molecular modeling and simulation technology, CLQ has been suggested to recognize the SAs and gangliosides. Human type Neu5Ac binds to CLQ and CLQ-OH. Thus, SAs are "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1093","span":{"begin":91,"end":94},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T1094","span":{"begin":127,"end":130},"obj":"http://purl.obolibrary.org/obo/CLO_0051568"},{"id":"T1095","span":{"begin":149,"end":154},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T1096","span":{"begin":198,"end":201},"obj":"http://purl.obolibrary.org/obo/CLO_0051568"}],"text":" the S glycoprotein of SARS-CoV-2. Using molecular modeling and simulation technology, CLQ has been suggested to recognize the SAs and gangliosides. Human type Neu5Ac binds to CLQ and CLQ-OH. Thus, SAs are "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T70796","span":{"begin":7,"end":19},"obj":"Chemical"},{"id":"T517","span":{"begin":135,"end":147},"obj":"Chemical"},{"id":"T21270","span":{"begin":160,"end":166},"obj":"Chemical"}],"attributes":[{"id":"A30331","pred":"chebi_id","subj":"T70796","obj":"http://purl.obolibrary.org/obo/CHEBI_17089"},{"id":"A67776","pred":"chebi_id","subj":"T517","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"},{"id":"A87285","pred":"chebi_id","subj":"T21270","obj":"http://purl.obolibrary.org/obo/CHEBI_17012"},{"id":"A49436","pred":"chebi_id","subj":"T21270","obj":"http://purl.obolibrary.org/obo/CHEBI_75133"}],"text":" the S glycoprotein of SARS-CoV-2. Using molecular modeling and simulation technology, CLQ has been suggested to recognize the SAs and gangliosides. Human type Neu5Ac binds to CLQ and CLQ-OH. Thus, SAs are "}

{"project":"LitCovid-sentences","denotations":[{"id":"T751","span":{"begin":35,"end":148},"obj":"Sentence"},{"id":"T752","span":{"begin":149,"end":191},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" the S glycoprotein of SARS-CoV-2. Using molecular modeling and simulation technology, CLQ has been suggested to recognize the SAs and gangliosides. Human type Neu5Ac binds to CLQ and CLQ-OH. Thus, SAs are "}